Parsec Financial Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $292K | Hold |
2,261
| – | – | 0.01% | 259 |
|
|
2022
Q4 | $297K | Hold |
2,261
| – | – | 0.01% | 251 |
|
|
2022
Q3 | $264K | Sell |
2,261
-336
| -13% | -$41.7K | 0.01% | 245 |
|
|
2022
Q2 | $305K | Hold |
2,597
| – | – | 0.01% | 245 |
|
|
2022
Q1 | $338K | Sell |
2,597
-12,195
| -82% | -$1.59M | 0.01% | 245 |
|
|
2021
Q4 | $2.26M | Sell |
14,792
-1,013
| -6% | -$157K | 0.09% | 131 |
|
|
2021
Q3 | $2.46M | Sell |
15,805
-2,639
| -14% | -$444K | 0.1% | 123 |
|
|
2021
Q2 | $3.02M | Sell |
18,444
-4,266
| -19% | -$657K | 0.14% | 110 |
|
|
2021
Q1 | $3.42M | Sell |
22,710
-1,452
| -6% | -$231K | 0.18% | 94 |
|
|
2020
Q4 | $3.66M | Sell |
24,162
-249
| -1% | -$35.6K | 0.2% | 86 |
|
|
2020
Q3 | $3.31M | Sell |
24,411
-929
| -4% | -$126K | 0.2% | 85 |
|
|
2020
Q2 | $3.46M | Sell |
25,340
-6,910
| -21% | -$881K | 0.22% | 85 |
|
|
2020
Q1 | $3.48M | Sell |
32,250
-2,231
| -6% | -$257K | 0.26% | 83 |
|
|
2019
Q4 | $4.16M | Sell |
34,481
-2,787
| -7% | -$311K | 0.24% | 87 |
|
|
2019
Q3 | $3.71M | Sell |
37,268
-1,563
| -4% | -$164K | 0.23% | 88 |
|
|
2019
Q2 | $4.24M | Sell |
38,831
-3,448
| -8% | -$367K | 0.26% | 82 |
|
|
2019
Q1 | $4.73M | Sell |
42,279
-1,624
| -4% | -$178K | 0.3% | 82 |
|
|
2018
Q4 | $4.23M | Sell |
43,903
-5,436
| -11% | -$577K | 0.31% | 79 |
|
|
2018
Q3 | $6.02M | Sell |
49,339
-2,187
| -4% | -$258K | 0.38% | 74 |
|
|
2018
Q2 | $5.66M | Sell |
51,526
-2,564
| -5% | -$274K | 0.38% | 74 |
|
|
2018
Q1 | $5.77M | Sell |
54,090
-871
| -2% | -$96.5K | 0.39% | 72 |
|
|
2017
Q4 | $5.87M | Sell |
54,961
-3,737
| -6% | -$399K | 0.4% | 77 |
|
|
2017
Q3 | $6.53M | Buy |
58,698
+582
| +1% | +$62.2K | 0.47% | 67 |
|
|
2017
Q2 | $6.01M | Buy |
58,116
+2,436
| +4% | +$240K | 0.48% | 70 |
|
|
2017
Q1 | $5.44M | Buy |
55,680
+12,345
| +28% | +$1.18M | 0.45% | 70 |
|
|
2016
Q4 | $3.83M | Buy |
43,335
+11,883
| +38% | +$1.08M | 0.33% | 83 |
|
|
2016
Q3 | $3.04M | Buy |
31,452
+8,556
| +37% | +$814K | 0.27% | 91 |
|
|
2016
Q2 | $1.96M | Buy |
22,896
+2,895
| +14% | +$260K | 0.19% | 106 |
|
|
2016
Q1 | $1.74M | Buy |
20,001
+915
| +5% | +$81.8K | 0.17% | 109 |
|
|
2015
Q4 | $2.15M | Buy |
19,086
+141
| +0.7% | +$15.3K | 0.22% | 105 |
|
|
2015
Q3 | $1.92M | Buy |
18,945
+10,245
| +118% | +$1.23M | 0.21% | 101 |
|
|
2015
Q2 | $1.07M | Buy |
8,700
+456
| +6% | +$54.6K | 0.11% | 113 |
|
|
2015
Q1 | $944K | Buy |
8,244
+1,755
| +27% | +$194K | 0.1% | 116 |
|
|
2014
Q4 | $656K | Buy |
6,489
+4,278
| +193% | +$416K | 0.07% | 114 |
|
|
2014
Q3 | $202K | Buy |
+2,211
| New | +$194K | 0.02% | 156 |
|
Other funds holding IBB
Parsec Financial Management's IBB Position: Q1 2023 in Review
Parsec Financial Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2023 at 2,261 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #259.
Parsec Financial Management first reported a position in IBB in Q3 2014 and has held it in 35 quarters since. The position peaked at $6.53M in Q3 2017. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.
- Parsec Financial Management held 2,261 shares of iShares Biotechnology ETF worth $292K as of Q1 2023.
- Parsec Financial Management left its iShares Biotechnology ETF share count unchanged in Q1 2023.
- iShares Biotechnology ETF made up 0.01% of Parsec Financial Management's portfolio in Q1 2023, its #259 holding.
- Parsec Financial Management first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 35 quarters since.
- Parsec Financial Management's iShares Biotechnology ETF position peaked at $6.53M in Q3 2017.
- 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.
Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.